FDA PMA FDA Class 3 Approved 🇺🇸 United States

Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing

PMA: P830055 · Supplement: S334 · Decision Feb 20, 2025
Classifications
1
FEI Numbers
35
Registration Numbers
35

Basic Information

Device Name
Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing
Trade Name
Attune Primary System
PMA Number
P830055
Supplement Number
S334
Device Class
FDA Class 3
Product Code
NJL
Generic Name
Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing
Medical Specialty
Unknown
Advisory Committee
Orthopedic
Decision
Approved
Decision Code
APPR
Decision Date
February 20, 2025
Date Received
September 27, 2024
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for two changes: i) change in the manufacturing consolidation process of antioxidant (Pentaerythritol tetrakis [3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate]) (AOX), Ultra-High Molecular Weight Polyethylene (UHMWPE) bar stock material for the Attune Cruciate Retaining Rotating Platform (CR RP) and the Attune Posterior Stabilized Rotating Platform (PS RP) tibial inserts components that belong to the Attune Primary System.ii) change in the sterilization process of the Attune Cruciate Retaining Rotating Platform (CR RP), Attune Posterior Stabilized Rotating Platform (PS RP) tibial inserts components and the Attune Medialized Anatomic and Medialized Dome Patellar Components that belong to the Attune Primary System from a single, high dose sterilization to a split-dose sterilization method through a combination of crosslinking AOX UHMWPE raw material and final terminal sterilization

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NJL Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing